Hjem › Livmorhalskreft › Maryland
Kliniske studier for Livmorhalskreft i Maryland
12 studier for Livmorhalskreft søker deltakere på steder i Maryland.
Byer i Maryland
Offisiell studietekst (engelsk)
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Johns Hopkins University, Baltimore
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06172478A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
- Maryland Oncology Hematology (MOH) ( Site 8001), Columbia
RekruttererFase 3
Alder 18 og eldre · Kvinner · Oppdatert 25. sep. 2026 · NCT07216703Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
- Research Site, Baltimore
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 11. sep. 2026 · NCT06535607A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- National Institutes of Health, Bethesda
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 11. aug. 2026 · NCT05592626GCCC 2578 Randomized Photon vs Proton RT for Newly Diagnosed Gynecologic Primaries
- Maryland Proton Treatment Center, Baltimore
- University of Maryland Greenebaum Cancer Center, Baltimore
- Upper Chesapeake Health, Bel Air
- og 2 flere
RekruttererFase 2
Alder 18 og eldre · Kvinner · Oppdatert 10. aug. 2026 · NCT07415681A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
RekruttererFase 1
Alder 18 og eldre · Kvinner · Oppdatert 1. jul. 2026 · NCT06315257E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 12. jun. 2026 · NCT05686226Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- Advanced Molecular Imaging and Therapy, Glen Burnie
- United Theranostics - Chesapeake, Glen Burnie
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 11. jun. 2026 · NCT05283330PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer
- National Institute of Health, Bethesda
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 23. apr. 2026 · NCT06157151Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 11. mar. 2026 · NCT03968406Image-Guided Gynecologic Brachytherapy
- The SKCCC at Johns Hopkins, Baltimore
Rekrutterer
Alder 18 til 100 · Kvinner · Oppdatert 18. des. 2025 · NCT02993900SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Bethesda
- Massive Bio SYNERGY-AI site, Silver Spring
- og 1 flere
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.